Arbutus Biopharma (ABUS) FCF Margin Growth (1y) (2014 - 2026)
Arbutus Biopharma (ABUS) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arbutus Biopharma |
882.62 Mn |
882.62 Mn |
- |
75,460.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
75,460.00 |
| Dec 31, 2025 |
21,551.00 |
| Sep 30, 2025 |
44,900.00 |
| Jun 30, 2025 |
69,373.00 |
| Mar 31, 2025 |
50,654.00 |
| Dec 31, 2024 |
14,535.00 |
| Sep 30, 2024 |
-108,026.00 |
| Jun 30, 2024 |
-40,138.00 |
| Mar 31, 2024 |
-85,565.00 |
| Dec 31, 2023 |
-53,195.00 |
| Sep 30, 2023 |
-15,278.00 |
| Jun 30, 2023 |
-29,502.00 |
| Mar 31, 2023 |
-57,331.00 |
| Dec 31, 2022 |
33,915.00 |
| Sep 30, 2022 |
16,514.00 |
| Jun 30, 2022 |
48,465.00 |
| Mar 31, 2022 |
101,422.00 |
| Dec 31, 2021 |
2,223.00 |
| Sep 30, 2021 |
31,935.00 |
| Jun 30, 2021 |
-4,297.00 |
